For: | Döbrönte Z, Szepes Z, Izbéki F, Gervain J, Lakatos L, Pécsi G, Ihász M, Lakner L, Toldy E, Czakó L. Is rectal indomethacin effective in preventing of post-endoscopic retrograde cholangiopancreatography pancreatitis? World J Gastroenterol 2014; 20(29): 10151-10157 [PMID: PMC4123345 DOI: 10.3748/wjg.v20.i29.10151] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i29/10151.htm |
Number | Citing Articles |
1 |
Jianhua Wan, Yuping Ren, Zhenhua Zhu, Liang Xia, Nonghua Lu. How to select patients and timing for rectal indomethacin to prevent post-ERCP pancreatitis: a systematic review and meta-analysis. BMC Gastroenterology 2017; 17(1) doi: 10.1186/s12876-017-0599-4
|
2 |
Venkata S. Akshintala, Kavin Kanthasamy, Furqan A. Bhullar, Christina J. Sperna Weiland, Ayesha Kamal, Bharati Kochar, Merve Gurakar, Saowanee Ngamruengphong, Vivek Kumbhari, Olaya I. Brewer-Gutierrez, Anthony N. Kalloo, Mouen A. Khashab, Erwin-Jan M. van Geenen, Vikesh K. Singh. Incidence, severity, and mortality of post-ERCP pancreatitis: an updated systematic review and meta-analysis of 145 randomized controlled trials. Gastrointestinal Endoscopy 2023; 98(1): 1 doi: 10.1016/j.gie.2023.03.023
|
3 |
|
4 |
Behzad Hatami, Seyed Mohammad Hossein Kashfi, Mohammad Abbasinazari, Ehsan Nazemalhosseini Mojarad, Mohammad Amin Pourhoseingholi, Mohammad Reza Zali, Amir Houshang Mohammad Alizadeh. Epinephrine in the Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Preliminary Study. Case Reports in Gastroenterology 2018; 12(1): 125 doi: 10.1159/000479494
|
5 |
Árpád Patai, Norbert Solymosi, László Mohácsi, Árpád V. Patai. Indomethacin and diclofenac in the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis of prospective controlled trials. Gastrointestinal Endoscopy 2017; 85(6): 1144 doi: 10.1016/j.gie.2017.01.033
|
6 |
Rajat Garg, Babu P. Mohan, Rajesh Krishnamoorthi, Tarun Rustagi. Pre-endoscopic retrograde cholangiopancreatography (ERCP) administration of rectal indomethacin in unselected patients to reduce post-ERCP pancreatitis: A systematic review and meta-analysis. Indian Journal of Gastroenterology 2018; 37(2): 120 doi: 10.1007/s12664-018-0841-1
|
7 |
Yin Shou-xin, Han Shuai, Kong Fan-guo, Dao Xing-yuan, Huang Jia-guo, Peng Tao, Qi Lin, Shang Yan-sheng, Yang Ting-ting, Zhao Jing, Li Fang, Qi Hao-liang, Liu Man. Rectal nonsteroidal anti-inflammatory drugs and pancreatic stents in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients. Medicine 2020; 99(42): e22672 doi: 10.1097/MD.0000000000022672
|
8 |
S K Roy, A Lambert. Obstructive jaundice: a clinical review for the UK armed forces. Journal of The Royal Naval Medical Service 2017; 103(1): 44 doi: 10.1136/jrnms-103-44
|
9 |
Xingkang He, Wenfang Zheng, Yue Ding, Xia Tang, Jianmin Si, Lei-min Sun. Rectal Indomethacin Is Protective against Pancreatitis after Endoscopic Retrograde Cholangiopancreatography: Systematic Review and Meta-Analysis. Gastroenterology Research and Practice 2018; 2018: 1 doi: 10.1155/2018/9784841
|
10 |
Hyoung‐Chul Oh, Hyun Kang, Tae Young Park, Geun Joo Choi, Glen A Lehman. Prevention of post‐endoscopic retrograde cholangiopancreatography pancreatitis with a combination of pharmacological agents based on rectal non‐steroidal anti‐inflammatory drugs: A systematic review and network meta‐analysis. Journal of Gastroenterology and Hepatology 2021; 36(6): 1403 doi: 10.1111/jgh.15303
|
11 |
Hironari Kato, Takeshi Tomoda, Akihiro Matsumi, Kazuyuki Matsumoto. Current status and issues for prediction and prevention of postendoscopic retrograde cholangiopancreatography pancreatitis. Digestive Endoscopy 2024; doi: 10.1111/den.14966
|
12 |
Rawad A. Yared, Chieh-Chang Chen, Astrid Vandorpe, Marianna Arvanitakis, Myriam Delhaye, Michael Fernandez Y. Viesca, Vincent Huberty, Daniel Blero, Emmanuel Toussaint, Axel Hittelet, Didier Verset, Walter Margos, Olivier Le Moine, Hassane Njimi, Wei-Chih Liao, Jacques Devière, Arnaud Lemmers. Intravenous Hemin, a potential heme oxygenase-1 activator, does not protect from post-ERCP acute pancreatitis in humans: Results of a randomized multicentric multinational placebo-controlled trial. Pancreatology 2024; 24(3): 363 doi: 10.1016/j.pan.2024.02.009
|
13 |
Lan Liu, Chenghao Li, Yuan Huang, Haiyan Jin. Nonsteroidal Anti-inflammatory Drugs for Endoscopic Retrograde Cholangiopancreatography Postoperative Pancreatitis Prevention: a Systematic Review and Meta-analysis. Journal of Gastrointestinal Surgery 2019; 23(10): 1991 doi: 10.1007/s11605-018-3967-7
|
14 |
Shuang Yu, Xumu Shen, Liang Li, Xiaofei Bi, Ping Chen, Wei Wu. Rectal indomethacin and diclofenac are equally efficient in preventing pancreatitis following endoscopic retrograde cholangiopancreatography in average‐risk patients. JGH Open 2021; 5(10): 1119 doi: 10.1002/jgh3.12643
|
15 |
Tae Young Park, Hyun Kang, Geun Joo Choi, Hyoung-Chul Oh. Rectal NSAIDs-based combination modalities are superior to single modalities for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a network meta-analysis. The Korean Journal of Internal Medicine 2022; 37(2): 322 doi: 10.3904/kjim.2021.410
|
16 |
Yi-Chao Hou, Qiang Hu, Jiao Huang, Jing-Yuan Fang, Hua Xiong. Efficacy and safety of rectal nonsteroidal anti-inflammatory drugs for prophylaxis against post-ERCP pancreatitis: a systematic review and meta-analysis. Scientific Reports 2017; 7(1) doi: 10.1038/srep46650
|
17 |
Fei Du, Yongxuan Zhang, Xiaozhou Yang, Lingkai Zhang, Wencong Yuan, Haining Fan, Li Ren. Efficacy of Combined Management with Nonsteroidal Anti-inflammatory Drugs for Prevention of Pancreatitis After Endoscopic Retrograde Cholangiography: a Bayesian Network Meta-analysis. Journal of Gastrointestinal Surgery 2022; 26(9): 1982 doi: 10.1007/s11605-022-05352-7
|
18 |
Bara El Kurdi, Zaid Imam, Abdulrahman Abonofal, Sumbal Babar, Pir Shah, Rahul Pannala, Georgios Papachristou, Juan Echavarria, Sailaja Pisipati, Sarah Jahangir, Prasad Rajalingamgari, Yu-Hui H. Chang, Vijay P. Singh. NSAIDs do not reduce severity among post-ERCP pancreatitis patients. Pancreatology 2024; 24(1): 14 doi: 10.1016/j.pan.2023.11.003
|
19 |
Salvatore F. Vadalà di Prampero, Giacomo Faleschini, Nikola Panic, Milutin Bulajic. Endoscopic and pharmacological treatment for prophylaxis against postendoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis and systematic review. European Journal of Gastroenterology & Hepatology 2016; 28(12): 1415 doi: 10.1097/MEG.0000000000000734
|
20 |
Víctor Fernando Andrade-Dávila, Mariana Chávez-Tostado, Carlos Dávalos-Cobián, Jesús García-Correa, Alejandro Montaño-Loza, Clotilde Fuentes-Orozco, Michel Dassaejv Macías-Amezcua, Jesús García-Rentería, Jorge Rendón-Félix, José Antonio Cortés-Lares, Gabriela Ambriz-González, Ana Olivia Cortés-Flores, Andrea del Socorro Alvarez-Villaseñor, Alejandro González-Ojeda. Rectal indomethacin versus placebo to reduce the incidence of pancreatitis after endoscopic retrograde cholangiopancreatography: results of a controlled clinical trial. BMC Gastroenterology 2015; 15(1) doi: 10.1186/s12876-015-0314-2
|
21 |
Katalin Márta, Noémi Gede, Zsolt Szakács, Margit Solymár, Péter Jenő Hegyi, Bálint Tél, Bálint Erőss, Áron Vincze, Marianna Arvanitakis, Ivo Boškoski, Marco J. Bruno, Péter Hegyi. Combined use of indomethacin and hydration is the best conservative approach for post-ERCP pancreatitis prevention: A network meta-analysis. Pancreatology 2021; 21(7): 1247 doi: 10.1016/j.pan.2021.07.005
|
22 |
Chong Yang, Yanting Zhao, Wentao Li, Shikai Zhu, Hongji Yang, Yu Zhang, Xi Liu, Nan Peng, Ping Fan, Xin Jin. Rectal nonsteroidal anti-inflammatory drugs administration is effective for the prevention of post-ERCP pancreatitis: An updated meta-analysis of randomized controlled trials. Pancreatology 2017; 17(5): 681 doi: 10.1016/j.pan.2017.07.008
|
23 |
Juan Pablo Román Serrano, José Jukemura, Samuel Galante Romanini, Paúl Fernando Guamán Aguilar, Juliana Silveira Lima de Castro, Isabela Trindade Torres, José Andres Sanchez Pulla, Otavio Micelli Neto, Eloy Taglieri, José Celso Ardengh. Nonsteroidal anti-inflammatory drug effectivity in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis: A systematic review and meta-analysis. World Journal of Gastrointestinal Endoscopy 2020; 12(11): 469-487 doi: 10.4253/wjge.v12.i11.469
|
24 |
Wiqas Ahmad, Nkechi A Okam, Chenet Torrilus, Dibyata Rana, Mst. Khaleda Khatun, Nusrat Jahan. Pharmacological Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: Where Do We Stand Now?. Cureus 2020; doi: 10.7759/cureus.10115
|
25 |
Zsolt Dubravcsik, István Hritz, Bánk Keczer, Péter Novák, Barbara Dorottya Lovász, László Madácsy. Network meta-analysis of prophylactic pancreatic stents and non-steroidal anti-inflammatory drugs in the prevention of moderate-to-severe post-ERCP pancreatitis. Pancreatology 2021; 21(4): 704 doi: 10.1016/j.pan.2021.04.006
|
26 |
Yunlu Feng, Udayakumar Navaneethan, Xiang Zhu, Shyam Varadarajulu, Ingrid Schwartz, Robert Hawes, Muhammad Hasan, Aiming Yang. Prophylactic rectal indomethacin may be ineffective for preventing post‐endoscopic retrograde cholangiopancreatography pancreatitis in general patients: A meta‐analysis. Digestive Endoscopy 2017; 29(3): 272 doi: 10.1111/den.12779
|
27 |
Kai-Ji Liu, Yang Hu, Shi-Bin Guo. Effect of rectal indomethacin on prevention of pancreatitis after ERCP for choledocholithiasis: a prospective randomized clinical trial. Revista Española de Enfermedades Digestivas 2023; doi: 10.17235/reed.2023.9899/2023
|
28 |
Lin Li, Zhen Han, Heming Yuan, Guozheng Zhang, Yuliang Jia, Chiyi He. Nonsteroidal anti‐inflammatory drugs reduce the incidence of post‐endoscopic retrograde cholangiopancreatography pancreatitis: a meta‐analysis. Journal of Hepato-Biliary-Pancreatic Sciences 2017; 24(9): 520 doi: 10.1002/jhbp.489
|
29 |
Laurens P. Janssens, Aishwarya Yamparala, John Martin, John O’Meara, William S. Harmsen, Thanmay Sathi, Elizabeth Lemke, Barham K. Abu Dayyeh, Aliana Bofill-Garcia, Bret T. Petersen, Andrew C. Storm, Mark Topazian, Eric J. Vargas, Vinay Chandrasekhara, Ryan J. Law. Incidence of Post-ERCP Pancreatitis in Patients Receiving Rectal Indomethacin vs. Compounded Rectal Diclofenac Prophylaxis. Digestive Diseases and Sciences 2024; 69(10): 3970 doi: 10.1007/s10620-024-08604-5
|
30 |
Murat Pekgöz. Post-endoscopic retrograde cholangiopancreatography pancreatitis: A systematic review for prevention and treatment. World Journal of Gastroenterology 2019; 25(29): 4019-4042 doi: 10.3748/wjg.v25.i29.4019
|
31 |
Ayaka Takaori, Tsukasa Ikeura, Yuichi Hori, Takashi Ito, Koh Nakamaru, Masataka Masuda, Toshiyuki Mitsuyama, Hideaki Miyoshi, Masaaki Shimatani, Makoto Takaoka, Kazuichi Okazaki, Makoto Naganuma. Rectally Administered Low-Dose Diclofenac Has No Effect on Preventing Post–Endoscopic Retrograde Cholangiopancreatography Pancreatitis. Pancreas 2021; 50(7): 1024 doi: 10.1097/MPA.0000000000001877
|
32 |
Dhruvil Radadiya, Bhaumik Brahmbhatt, Chakradhar Reddy, Kalpit Devani. Efficacy of Combining Aggressive Hydration With Rectal Indomethacin in Preventing Post-ERCP Pancreatitis. Journal of Clinical Gastroenterology 2022; 56(3): e239 doi: 10.1097/MCG.0000000000001523
|
33 |
Sumant Inamdar, Dennis Han, Monica Passi, Divyesh V. Sejpal, Arvind J. Trindade. Rectal indomethacin is protective against post-ERCP pancreatitis in high-risk patients but not average-risk patients: a systematic review and meta-analysis. Gastrointestinal Endoscopy 2017; 85(1): 67 doi: 10.1016/j.gie.2016.08.034
|
34 |
Mohammad Karami, Bahman Salemi, Mohammad Shafigh Ardestani. Determination of the Effectiveness of Epinephrine Spray on the Papillae in Preventing Pancreatitis after Endoscopic Retrograde Cholangiopancreatography. Advanced Biomedical Research 2023; 12(1) doi: 10.4103/abr.abr_321_21
|
35 |
Elias Makhoul, Joe El Mir, Marc Harb. Does rectal ketoprofen prevent post ERCP pancreatitis?. Arab Journal of Gastroenterology 2019; 20(3): 141 doi: 10.1016/j.ajg.2019.09.004
|
36 |
Charles de Mestral. Simple pharmacological prophylaxis for post-ERCP pancreatitis. The Lancet 2016; 387(10035): 2265 doi: 10.1016/S0140-6736(16)30312-9
|
37 |
Tadahiro Takada, Shuji Isaji, Toshihiko Mayumi, Masahiro Yoshida, Yoshifumi Takeyama, Takao Itoi, Keiji Sano, Yusuke Iizawa, Atsushi Masamune, Morihisa Hirota, Kohji Okamoto, Dai Inoue, Nobuya Kitamura, Yasuhisa Mori, Shuntaro Mukai, Seiki Kiriyama, Kunihiro Shirai, Asuka Tsuchiya, Ryota Higuchi, Teijiro Hirashita. JPNclinical practice guidelines 2021 with easy‐to‐understand explanations for the management of acute pancreatitis. Journal of Hepato-Biliary-Pancreatic Sciences 2022; 29(10): 1057 doi: 10.1002/jhbp.1146
|
38 |
Hui Luo, Lina Zhao, Joseph Leung, Rongchun Zhang, Zhiguo Liu, Xiangping Wang, Biaoluo Wang, Zhanguo Nie, Ting Lei, Xun Li, Wence Zhou, Lingen Zhang, Qi Wang, Ming Li, Yi Zhou, Qian Liu, Hao Sun, Zheng Wang, Shuhui Liang, Xiaoyang Guo, Qin Tao, Kaichun Wu, Yanglin Pan, Xuegang Guo, Daiming Fan. Routine pre-procedural rectal indometacin versus selective post-procedural rectal indometacin to prevent pancreatitis in patients undergoing endoscopic retrograde cholangiopancreatography: a multicentre, single-blinded, randomised controlled trial. The Lancet 2016; 387(10035): 2293 doi: 10.1016/S0140-6736(16)30310-5
|
39 |
Fausto Fiocca, Gianfranco Fanello, Fabrizio Cereatti, Roberta Maselli, Vincenzo Ceci, Gianfranco Donatelli. Early ‘shallow’ needle-knife papillotomy and guidewire cannulation: an effective and safe approach to difficult papilla. Therapeutic Advances in Gastroenterology 2015; 8(3): 114 doi: 10.1177/1756283X15576466
|
40 |
Jiahui Yang, Wancong Wang, Chuan Liu, Yan Zhao, Mudan Ren, Shuixiang He. Rectal Nonsteroidal Anti-Inflammatory Drugs for Endoscopic Retrograde Cholangiopancreatography Postoperative Pancreatitis Prevention. Journal of Clinical Gastroenterology 2020; 54(4): 305 doi: 10.1097/MCG.0000000000001322
|
41 |
Yunxiao Lyu, Yunxiao Cheng, Bin Wang, Yueming Xu, Weibing Du. What is impact of nonsteroidal anti-inflammatory drugs in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials. BMC Gastroenterology 2018; 18(1) doi: 10.1186/s12876-018-0837-4
|
42 |
Edgar Julián Rojas-Victoria, Sara Isabel Hernández-Ruiz, Herney Andrés García-Perdomo. Effectiveness of the pharmacological therapy to prevent post ERCP acute pancreatitis: a network meta-analysis. Expert Review of Gastroenterology & Hepatology 2024; 18(4-5): 203 doi: 10.1080/17474124.2024.2345640
|
43 |
Mohammad Yaghoobi, Mohammed A Alzahrani, Julia McNabb-Baltar, Myriam Martel, Alan N Barkun. Rectal Indomethacin Prevents Moderate to Severe Post-ERCP Pancreatitis and Death and Should Be Used Before the Procedure: A Meta-Analysis of Aggregate Subgroup Data. Journal of the Canadian Association of Gastroenterology 2018; 1(2): 67 doi: 10.1093/jcag/gwy006
|
44 |
Shaffer R.S. Mok, Henry C. Ho, Paurush Shah, Milan Patel, John P. Gaughan, Adam B. Elfant. Lactated Ringer's solution in combination with rectal indomethacin for prevention of post-ERCP pancreatitis and readmission: a prospective randomized, double-blinded, placebo-controlled trial. Gastrointestinal Endoscopy 2017; 85(5): 1005 doi: 10.1016/j.gie.2016.10.033
|
45 |
飞 杜. Efficacy of Combination of Nonsteroidal Anti-Inflammatory Drugs for Prevention of Pancreatitis after Endoscopic Retrograde Cholangiography—A Bayesian Network Meta-Analysis. Advances in Clinical Medicine 2022; 12(02): 1267 doi: 10.12677/ACM.2022.122185
|
46 |
UEG Week 2016 Oral Presentations. United European Gastroenterology Journal 2016; 4(5_suppl): A1 doi: 10.1177/2050640616663688
|
47 |
Qing-Qing Shi, Guo-Xiu Huang, Wei Li, Jian-Rong Yang, Xiao-Yi Ning. Rectal nonsteroidal anti-inflammatory drugs, glyceryl trinitrate, or combinations for prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis: A network meta-analysis. World Journal of Clinical Cases 2022; 10(22): 7859-7871 doi: 10.12998/wjcc.v10.i22.7859
|
48 |
Jin Ho Choi, Sang Hyub Lee. Pharmachologic Prophylaxis for Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis. The Korean Journal of Pancreas and Biliary Tract 2021; 26(3): 148 doi: 10.15279/kpba.2021.26.3.148
|
49 |
Chongrong Shen, Yanqiang Shi, Tianyu Liang, Peizhu Su. Rectal NSAIDs in the prevention of post‐endoscopic retrograde cholangiopancreatography pancreatitis in unselected patients: Systematic review and meta‐analysis. Digestive Endoscopy 2017; 29(3): 281 doi: 10.1111/den.12816
|
50 |
Mia Rainio, Outi Lindström, Marianne Udd, Johanna Louhimo, Leena Kylänpää. Diclofenac Does Not Reduce the Risk of Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis in Low-Risk Units. Journal of Gastrointestinal Surgery 2017; 21(8): 1270 doi: 10.1007/s11605-017-3412-3
|
51 |
Lei-Min Yu, Ke-Jia Zhao, Bin Lu. Use of NSAIDs via the Rectal Route for the Prevention of Pancreatitis after ERCP in All-Risk Patients: An Updated Meta-Analysis. Gastroenterology Research and Practice 2018; 2018: 1 doi: 10.1155/2018/1027530
|